Verastem is a biopharmaceutical company that develops medicines for cancer. Its work centres on drugs that block specific signalling pathways inside tumour cells, with programmes aimed at cancers of the blood and at solid tumours. The company carries out research and clinical testing of these candidate therapies and works toward bringing them to patients through the regulatory process. Verastem is based in Needham, Massachusetts, in the United States.
The shares are listed on the London Exchange in UK under the code 0LOV, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1720 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
91/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average61.6%
From 52-week high-7.0%
MomentumStrong
80/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return55.7%
6-month return59.0%
12-month, skipping last month0.3%
Stability (higher is calmer)Weak
11/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)76.4%
Worst drawdown, 1 year (smaller is calmer)-67.1%
LiquidityWeak
29/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.09M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 3.440 – 10.665Daily closes, split-adjusted
Signals
50-day average7.882
200-day average6.071
Golden/death cross (60d)Golden, 33 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.716
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
6 bullish · 1 neutral · 1 bearish
Moving averages (daily)
SMA 10
8.95
Bullish
EMA 10
9.12
Bullish
SMA 20
8.47
Bullish
EMA 20
8.67
Bullish
SMA 50
7.88
Bullish
EMA 50
7.87
Bullish
SMA 100
6.47
Bullish
EMA 100
7.11
Bullish
SMA 200
6.07
Bullish
EMA 200
6.70
Bullish
Oscillators (daily)
RSI (14)
64.99
Neutral
MACD (12, 26)
0.52
Bullish
Momentum (12)
19.22
Bullish
Stochastic %K (14)
88.24
Bearish
Williams %R (14)
-11.76
Bearish
CCI (20)
175.2
Bearish
Pivot points (classic, last session)
S3
9.14
S2
9.44
S1
9.62
Pivot
9.92
R1
10.11
R2
10.41
R3
10.60
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
